Matthew D Shin
Overview
Explore the profile of Matthew D Shin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
415
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Unleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination
Pereira-Silva M, Chauhan G, Shin M, Hoskins C, Madou M, Martinez-Chapa S, et al.
Expert Opin Drug Deliv
. 2021 May;
18(10):1395-1414.
PMID: 33944644
: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a particular coronavirus strain responsible for the coronavirus disease 2019 (COVID-19), accounting for more than 3.1 million deaths worldwide. Several health-related...
12.
Kim Y, Hsueh H, Shin M, Berlinicke C, Han H, Anders N, et al.
Drug Deliv Transl Res
. 2021 Apr;
12(4):826-837.
PMID: 33900546
While eye drops are the most common ocular dosage form, eye drops for treating diseases of the posterior segment (retina, choroid, optic nerve) have yet to be developed. In glaucoma,...
13.
Kim Y, Shin M, Hackett S, Hsueh H, Lima E Silva R, Date A, et al.
Nat Biomed Eng
. 2020 Sep;
4(11):1053-1062.
PMID: 32895514
Eye-drop formulations should hold as high a concentration of soluble drug in contact with ocular epithelium for as long as possible. However, eye tears and frequent blinking limit drug retention...
14.
Shin M, Shukla S, Chung Y, Beiss V, Chan S, Ortega-Rivera O, et al.
Nat Nanotechnol
. 2020 Jul;
15(8):646-655.
PMID: 32669664
The COVID-19 pandemic has infected millions of people with no clear signs of abatement owing to the high prevalence, long incubation period and lack of established treatments or vaccines. Vaccines...